These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7669941)
1. Metabolic effects of carbocalcitonin and salmon calcitonin, after endonasal administration in man. Cecchettin M; Segre G Biomed Pharmacother; 1995; 49(4):215-8. PubMed ID: 7669941 [TBL] [Abstract][Full Text] [Related]
2. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins]. Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the biological activity of unmodified synthetic eel calcitonin rectal capsules. Comparison with intramuscular administration and placebo. Fiore CE; Fiorito S; Foti R; Motta M; Incognito C; Grasso G Int J Clin Pharmacol Res; 1992; 12(4):185-9. PubMed ID: 1338433 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects. Reginster JY; Denis D; Albert A; Franchimont P Bone Miner; 1987 Apr; 2(2):133-40. PubMed ID: 3504725 [TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of rectal administration of unmodified eel calcitonin in humans. Nuti R; Martini G; Frediani B; Giovani S; Valenti R; Marcocci A; Ciappi A Drugs Exp Clin Res; 1992; 18(9):395-400. PubMed ID: 1338592 [TBL] [Abstract][Full Text] [Related]
6. The effect of different doses of nasal salmon calcitonin on plasma cyclic AMP and serum ionized calcium. Thamsborg G; Storm TL; Brinch E; Sykulski R; Fogh-Andersen N; Holmegaard SN; Sørensen OH Calcif Tissue Int; 1990 Jan; 46(1):5-8. PubMed ID: 2153040 [TBL] [Abstract][Full Text] [Related]
7. [Profile of a new calcitonin: carbocalcitonin-(Asu1,7) E-CT]. Nogarin L; Passarella E Minerva Med; 1984 Jul; 75(30-31):1809-18. PubMed ID: 6207466 [TBL] [Abstract][Full Text] [Related]
8. Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women. Overgaard K; Agnusdei D; Hansen MA; Maioli E; Christiansen C; Gennari C J Clin Endocrinol Metab; 1991 Feb; 72(2):344-9. PubMed ID: 1846873 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the biological activity of synthetic salmon calcitonin by intranasal administration in healthy volunteers. Fiore CE; Romagnoli A; Foti R; Coppini A Drugs Exp Clin Res; 1991; 17(10-11):537-42. PubMed ID: 1668656 [TBL] [Abstract][Full Text] [Related]
10. Biological activity of different calcitonins in men. Gennari C; Gonnelli S; Agnusdei D; Civitelli R Exp Gerontol; 1990; 25(3-4):339-47. PubMed ID: 2171971 [TBL] [Abstract][Full Text] [Related]
11. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man. Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347 [TBL] [Abstract][Full Text] [Related]
12. Hypocalcemic effects of rectal and intramuscular administration of synthetic salmon calcitonin. Pagani G; Pagani MD; Gianola D; Pedroncelli A; Cortesi L; Gherardi F; Gualteroni L; Tengattini F; Montini M Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):329-32. PubMed ID: 1743807 [TBL] [Abstract][Full Text] [Related]
13. [Renal production and excretion of AMPc after intravenous infusion of salmon calcitonin in man]. Kuhn JM; Cazor JL; Isaac R; Nivez MP; Ardaillou R; Fillastre JP C R Seances Soc Biol Fil; 1976; 170(2):449-55. PubMed ID: 183875 [TBL] [Abstract][Full Text] [Related]
14. [Inhibition of gastroenteral absorption of 45Ca by synthetic salmon calcitonin (author's transl)]. Heuer LJ Arzneimittelforschung; 1982; 32(1):32-4. PubMed ID: 7199338 [TBL] [Abstract][Full Text] [Related]
15. Stability and the biological activity of eel calcitonin in rats. Otani M; Kitazawa S; Yamauchi H; Meguro T; Orimo H Horm Metab Res; 1978 May; 10(3):252-6. PubMed ID: 669568 [TBL] [Abstract][Full Text] [Related]
16. [Prevention of post-ovariectomy osteoporosis in the rat. Comparative study of synthetic salmon calcitonin and eel calcitonin aminosuberic analogue]. Gnudi S; Zati A; Giardino R; Fini M; Pratelli L; Orlandi M; Figus E Minerva Endocrinol; 1993 Sep; 18(3):123-7. PubMed ID: 8183179 [TBL] [Abstract][Full Text] [Related]
17. Intranasal absorption of salmon calcitonin. Kurose H; Seino Y; Shima M; Tanaka H; Ishida M; Yamaoka K; Yabuuchi H Calcif Tissue Int; 1987 Nov; 41(5):249-51. PubMed ID: 3121148 [TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats. Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin. McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704 [TBL] [Abstract][Full Text] [Related]
20. [Intranasal absorption of various calcitonin spray preparations]. Pisati P; Feletti F; De Bernardi M; Tripodi AS; Contos S; Germogli R; Molteni R; Covini D Boll Chim Farm; 1992 Mar; 131(3):120-7. PubMed ID: 1418891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]